We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
-12.91%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$131B
AUM Growth
-$19.5B
Cap. Flow
+$2.76B
Cap. Flow %
2.11%
Top 10 Hldgs %
14.61%
Holding
3,199
New
67
Increased
1,772
Reduced
1,049
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$361M
2
CVS icon
CVS Health
CVS
+$180M
3
CI icon
Cigna
CI
+$158M
4
MSFT icon
Microsoft
MSFT
+$102M
5
AMZN icon
Amazon
AMZN
+$90M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 13.99%
3 Healthcare 13.63%
4 Industrials 10.39%
5 Consumer Discretionary 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSG icon
3126
Inseego
INSG
$114M
$58K ﹤0.01%
1,390
BBGI icon
3127
Beasley Broadcasting Group
BBGI
$38M
$57K ﹤0.01%
753
CLSD
3128
DELISTED
Clearside Biomedical
CLSD
$56K ﹤0.01%
3,473
-542
-13% -$25.4K
CVRS
3129
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$55K ﹤0.01%
+65,150
New +$77.7K
ZN
3130
DELISTED
Zion Oil & Gas, Inc.
ZN
$52K ﹤0.01%
122,348
SCPH
3131
DELISTED
scPharmaceuticals
SCPH
$51K ﹤0.01%
13,400
FBIO icon
3132
Fortress Biotech
FBIO
$104M
$49K ﹤0.01%
3,793
PHIIK
3133
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$46K ﹤0.01%
24,752
KEG
3134
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$44K ﹤0.01%
20,930
-3,071
-13% -$22.4K
CRMD icon
3135
CorMedix
CRMD
$584M
$39K ﹤0.01%
+5,920
New +$39.6K
ARC
3136
DELISTED
ARC Document Solutions, Inc.
ARC
$37K ﹤0.01%
17,626
QES
3137
DELISTED
Quintana Energy Services Inc.
QES
$36K ﹤0.01%
10,200
SGYP
3138
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$36K ﹤0.01%
312,756
-936,991
-75% -$615K
TLPH icon
3139
Talphera
TLPH
$68M
$34K ﹤0.01%
735
LEE icon
3140
Lee Enterprises
LEE
$168M
$33K ﹤0.01%
1,545
EYPT icon
3141
EyePoint Inc
EYPT
$1.02B
$28K ﹤0.01%
+1,460
New +$35.3K
TEUM
3142
DELISTED
Pareteum Corporation
TEUM
$27K ﹤0.01%
15,774
NH
3143
DELISTED
NantHealth, Inc
NH
$17K ﹤0.01%
2,033
IMUX icon
3144
Immunic
IMUX
$191M
$11K ﹤0.01%
142
ONCT
3145
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$9K ﹤0.01%
75
-23
-23% -$4.6K
BE icon
3146
Bloom Energy
BE
$62.6B
-6,100
Closed -$208K
CMCT
3147
Creative Media & Community Trust
CMCT
$9.73M
0
-$147K
FSFG
3148
DELISTED
First Savings Financial Group
FSFG
-10,500
Closed -$239K
IFRX icon
3149
InflaRx
IFRX
$249M
-46,310
Closed -$1.59M
IRMD icon
3150
iRadimed
IRMD
$1.19B
-7,834
Closed -$292K

Similar funds

Charles Schwab's Q4 2018 Portfolio in Review

As of Q4 2018, Charles Schwab held 3,199 positions worth $131B, down 13% from $150B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2018: portfolio turnover was 3.8%. Charles Schwab opened 67 new positions and exited 53, leaving the 3,199-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2018 buy was Linde: 2,286,208 shares worth $357M.
  • Charles Schwab added most to CVS Health in Q4 2018, an estimated $180M increase.
  • Charles Schwab's biggest Q4 2018 reduction was Qualcomm, cutting an estimated $42.7M.
  • Charles Schwab fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $301M.
  • Charles Schwab's ten largest holdings make up 15% of its $131B portfolio in Q4 2018.
  • Charles Schwab opened 67 new positions and closed 53 in Q4 2018.
  • Charles Schwab's portfolio value fell 13% quarter-over-quarter to $131B.

Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.